ADRB2 and cancer: Elevated levels of catecholamines also activate β2-adrenergic receptor (ADRβ2)-mediated cyclic adenosine monophosphate (cAMP) signaling pathways in tumor cells [3], which subsequently produce changes in the extracellular architecture that allow for further tissue invasion and metastasis by cancer cells.